Efficacy of a Selective Estrogen Receptor Modulator: ‘Ormeloxifene’ in Management of Dysfunctional Uterine Bleeding
article
OA: bronze
CC0
⤵ 4 in-corpus citations
Abstract
Background: Ormeloxifene, a third generation selective estrogen receptor modulator, has been claimed to ameliorate symptoms of DUB. This study was undertaken to compare the efficacy of ormeloxifene and norethisterone.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States 1982
- Do British women undergo too many or too few hysterectomies? 1988
- The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia 1987
Cited by (4)
- The role of Sevista (ormeloxifene) in the management of dysfunctional uterine bleeding 2016
- A double blinded randomized controlled trial to compare Ormeloxifene and Norethisterone in the treatment of Dysfunctional Uterine Bleeding 2014
- Comparative study to evaluate efficacy of 30 mg of ormeloxifene to 60 mg of ormeloxifene in cases of dysfunctional uterine bleeding 2016
- Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia 2014
References (16)
- Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States via openalex
- Do British women undergo too many or too few hysterectomies? via openalex
- The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex
- W2011448650 via openalex
- W2026954362 via openalex
- W2031785143 via openalex
- W2042374015 via openalex
- W2058960570 via openalex
- W2086126831 via openalex
- W2091692603 via openalex
- W2112710784 via openalex
- W2135574381 via openalex
- W63062164 via openalex
- W4299990226 via openalex
- W1955010715 via openalex
- W2002992487 via openalex
Cited by (4)
- The role of Sevista (ormeloxifene) in the management of dysfunctional uterine bleeding 2016
- Comparative study to evaluate efficacy of 30 mg of ormeloxifene to 60 mg of ormeloxifene in cases of dysfunctional uterine bleeding 2016
- A double blinded randomized controlled trial to compare Ormeloxifene and Norethisterone in the treatment of Dysfunctional Uterine Bleeding 2014
- Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia 2014
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK